Cargando…
BTLA-HVEM Couple in Health and Diseases: Insights for Immunotherapy in Lung Cancer
Lung cancer is the leading cause of cancer deaths worldwide. Immunotherapies (IT) have been rapidly approved for lung cancer treatment after the spectacular results in melanoma. Responses to the currently used checkpoint inhibitors are strikingly good especially in metastatic diseases. However, dura...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438526/ https://www.ncbi.nlm.nih.gov/pubmed/34532285 http://dx.doi.org/10.3389/fonc.2021.682007 |